课题基金 / 基金详情

Synthesis and action of mineralocorticoids in cardiovascular systems

Synthesis and action of mineralocorticoids in cardiovascular systems
盐皮质激素的合成及其在心血管系统中的作用
批准号:
16570122
负责人:
MUKAI Kuniaki
金额:
$2.43万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

MUKAI Kuniaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Aldosterone is a most potent mineralocorticoid which regulates water and electrolyte metabolisms in mammals. This steroid hormone is synthesized and secreted from the zona glomerulosa of adrenal cortex, and acts through mineralocorticoid receptor (MR) in the epithelial cells transport water and electrolytes. Recently, however, evidence that aldosterone is synthesized in the cardiovascular systems and acts in a paracrine manner through MR has been reported. It has been known that aldosterone is involved in cardiac hypertrophy and fibrosis and in homeostasis of vasculature. In this study, we examined molecular basis for synthesis and action of aldosterone in the cardiovascular systems. Examination of mRNA level of aldosterone synthase in aortas and hearts of normal rats showed that it was detectable but almost at its detection limit. mRNAs of factors responsible for aldosterone action were easily detectable. Next, we employed Dahl salt-sensitive rats fed on 8% NaCl-containing diets as an … More animal model for aldosterone-inducible heart failure. Salt-loading resulted in induction of aldosterone synthase mRNA frequently, while expression levels of the factors for aldosterone action mostly did not changed. Interestingly, expression of a newly cloned factor AZ-1, whose expression correlates with aldosterone synthesis and action, was enhanced in aortas and hearts significantly. Furthermore, we used another experimental animal model of cardiac hypertrophy and fibrosis by continuous administration (6 weeks) of aldosterone into normal rats fed on 1% NaCl-containing drinking water. The aldosterone administration caused hypertension with systolic blood pressure at 170 mmHg. Judging from histochemical analysis of the hearts they showed hypertrophy with accumulating collagenous fibrils. Immunohistochemical examination with anti-AZ-1 antibody revealed that AZ-1 became detectable in capillaries and interstitial spaces between cardiac muscle cells. Aldosterone caused cardiac hypertrophy and fibrosis through MR and induced expression of extracellular matrix proteins including AZ-1. Less
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
Characterization of AZ-1 protein : a member of proteolytically inactive preprocathepsin B-related proteins with cysteine-rich sequence
AZ-1 蛋白的表征:具有富含半胱氨酸序列的蛋白水解失活前组织蛋白酶 B 相关蛋白的成员
DOI: --
发表时间: 2004
期刊: 生化学 76・8
影响因子: --
作者: [向井邦晃, 他]
通讯作者:
副腎皮質の眉分化制御因子の同定
肾上腺皮质眉毛分化调节因素的鉴定
DOI: --
发表时间: 2004
期刊: 日本内分泌学会詰 80・2
影响因子: --
作者: [Mitani, F., Shin-ichi Imai, 向井邦晃]
通讯作者: 向井邦晃
Possible participation of outer mitochondrial membrane cytochrome b5 in steroidogenesis in zona glomerulosa of rat adrenal cortex
线粒体外膜细胞色素b5可能参与大鼠肾上腺皮质球状带类固醇生成
DOI: --
发表时间: 2004
期刊: Endocrine Res. 30
影响因子: --
作者: [Mitani, F.]
通讯作者: F.
副腎皮質のステロイドホルモン産生系におけるアスコルビン酸の役割
抗坏血酸在肾上腺皮质类固醇激素产生系统中的作用
DOI: --
发表时间: 2004
期刊: 日本内分泌学会誌 80・2
影响因子: --
作者: [三谷芙美子, 他]
通讯作者:
15
    Inhibitory action of a matricellular protein AZ-1 on vascular endothelium growth factor-receptor
    • 批准号:
      21510229
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      MUKAI Kuniaki
    • 依托单位:
    A novel secretory protein identified from an adrenocortical precursor cell-line
    • 批准号:
      13680724
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2001
    • 负责人:
      MUKAI Kuniaki
    • 依托单位:
    Regulatory mechanisms for differentiation of adrenocortical cells
    • 批准号:
      10680621
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      1998
    • 负责人:
      MUKAI Kuniaki
    • 依托单位:
    海外基金